难溶药物格列美脲的片剂处方设计及溶出评价

  • 李海鹰 ,
  • 杨文智 ,
  • 马丽兰 ,
  • 李霞霞 ,
  • 申世刚
展开
  • 1.河北大学药学院,河北保定071002;河北大学化学与环境科学学院,河北保定071002; 2.河北大学药学院,河北保定,071002; 3.河北大学化学与环境科学学院,河北保定,071002

网络出版日期: 2014-09-25

基金资助

河北省科技计划项目,河北大学精品实验项目2014

Preparation and dissolution rate evaluation of glimepiride tablets

  • LI Haiying ,
  • YANG Wenzhi ,
  • MA Lilan ,
  • LI Xiaxia ,
  • SHEN Shigang
Expand

Online published: 2014-09-25

摘要

采用研磨法混合主辅料,经湿法制粒压片,自制格列美脲片(GMT)和羟丙基-β-环糊精格列美脲片(HP-β-CDGMT)并对其进行质量评价.制备的片剂中崩解剂为质量分数5%低取代羟丙基纤维素,稀释剂为预胶化淀粉与微晶纤维(质量比5∶1),黏合剂为质量分数10%淀粉浆.2种自制片的片重差异、脆碎度、含量和含量均匀度,均符合2010版中国药典规定.HP-β-CDGMT溶出与GMT相比,明显得到改善.添加HP--CD辅料的优化片剂处方,工艺简单易行且自制HP-β-CDGMT主药溶出符合美国药典(USP 35)要求.

本文引用格式

李海鹰 , 杨文智 , 马丽兰 , 李霞霞 , 申世刚 . 难溶药物格列美脲的片剂处方设计及溶出评价[J]. 河北大学学报(自然科学版), 2014 , 34(5) : 491 -496 . DOI: 10.3969/j.issn.1000-1565.2014.05.009

参考文献

[1] 杨文智, 王芳, 李海鹰, 张亚静, 李月龙, YANG Wen-zhi, WANG Fang, LI Hai-ying, ZHANG Ya-jing, LI Yue-long. 环糊精诺氟沙星片剂的制备及溶出度考察 [J]. 河北大学学报(自然科学版) 2012.doi:10.3969/j.issn.1000-1565.2012.04.007
[2] 陶涛. 羟丙基倍他环糊精的特性及其药剂学应用 [J]. 中国医药工业杂志 2002.doi:10.3969/j.issn.1001-8255.2002.06.018
[3] 杨晓菊, 谢沐风, YANG Xiaoju, XIE Mufeng. 不同厂家格列美脲片溶出度的比较 [J]. 中国医药工业杂志 2008.doi:10.3969/j.issn.1001-8255.2008.10.013
[4] 卢毅, 张彤, 陶建生, 林敏, LU Yi, ZHANG Tong, TAO Jian-sheng, LIN Min. 京尼平-β-环糊精包合物制备工艺研究 [J]. 中国药学杂志 2008.doi:10.3321/j.issn:1001-2494.2008.20.011
[5] Massi Benedetti M. Glimepiride in type 2 diabetes mellitus: a review of the worldwide therapeutic experience. [J]. Clinical therapeutics 2003, 3(3).
[6] AMMAR H O, SALAMA H A, GHORAB M. Inclusion complexation of glimepiride in dimethyl-β-cyclodextrin [J]. Asian Journal of Pharmaceutical Sciences 2007, 2(02).
[7] Seedher N, Kanojia M. Co-solvent solubilization of some poorly-soluble antidiabetic drugs. [J]. Pharmaceutical development and technology 2009, 2(2).
[8] Reven S, Grdadolnik J, Kristl J, Zagar E. Hyperbranched poly(esteramides) as solubility enhancers for poorly water-soluble drug glimepiride. [J]. International Journal of Pharmaceutics 2010, 1/2(1/2).
[9] Ammar HO, Salama HA, Ghorab M, Mahmoud AA. Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems. [J]. International Journal of Pharmaceutics 2006, 1/2(1/2).
[10] Ammar HO, Salama HA, Ghorab M, Mahmoud AA. Implication of inclusion complexation of glimepiride in cyclodextrin-polymer systems on its dissolution, stability and therapeutic efficacy. [J]. International Journal of Pharmaceutics 2006, 1/2(1/2).
[11] LAJOS S, JOZSEF S. Highly soluble cyclodextrin derivatives:chemistry, properties and trends in development [J]. Advanced Drug Delivery Reviews 1999, 36(01).
[12] 高立军, 王维贤, 魏君, 谢剑炜. 格列美脲片溶出度方法的研究 [J]. 2002.
[13] KIRAN T, SHASTRI N, RAMAKRISHNA S. Surface solid dispersion of glimepiride for enhancement of dissolution rate [J]. Int J Pharm Tech Res 2009, 1(03).
[14] 梅兴国. 微载体药物递送系统 [M]. 武汉:华中科技大学出版社 2009.
[15] Riekes, M.K., Tagliari, M.P., Granada, A., Kuminek, G., Silva, M.A.S., Stulzer, H.K.. Enhanced solubility and dissolution rate of amiodarone by complexation with β-cyclodextrin through different methods [J]. Materials science & engineering, C. Biomimetic and supramolecular systems 2010, 7(7).
文章导航

/

〈 〉